Identifying PIK3CA, AKT1 and PTEN-Altered HR+/HER2- Advanced Breast Cancers

This session aims to support pathologists in understanding the importance of the PI3K/AKT/PTEN pathway in HR+/HER2- aBC and identifying all the actionable biomarkers in this pathway via NGS panel testing.